Susceptibility for breast cancer in young patients with short rare minisatellite alleles of BORIS

In this study, we characterized two blocks of minisatellites in the 5' upstream region of the BORIS gene (BORIS-MS1, -MS2). BORIS-MS2 was found to be polymorphic; therefore, this locus could be useful as a marker for DNA fingerprinting. We assessed the association between BORIS-MS2 and breast c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMB reports 2010, 43(10), , pp.698-703
Hauptverfasser: Yoon, S.L., Dong-A University, Busan, Republic of Korea, Kim, D.C., Dong-A University College of Medicine, Busan, Republic of Korea, Cho, S.H., Dong-A University College of Medicine, Busan, Republic of Korea, Lee, S.Y., Dong-A University, Busan, Republic of Korea, Chu, I.S., Korean Bioinformation Center, KRIBB, Daejeon, Republic of Korea, Heo, J.H., Kosin University College of Medicine, Busan, Republic of Korea, Leem, S.H., Dong-A University, Busan, Republic of Korea
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this study, we characterized two blocks of minisatellites in the 5' upstream region of the BORIS gene (BORIS-MS1, -MS2). BORIS-MS2 was found to be polymorphic; therefore, this locus could be useful as a marker for DNA fingerprinting. We assessed the association between BORIS-MS2 and breast cancer by a case-control study with 428 controls and 793 breast cancers cases. Rare alleles in the younger group (age, less than 40) were associated with a statistically significant increased risk of breast cancer (odds ratio, 4.84; 95% confidence interval, 1.06-22.22; and P = 0.026). A statistically significant association between the short rare alleles and cancer was identified in the younger group (8.02; 1.01-63.83; P = 0.021). Kaplan-Meier estimates showed that poor prognosis was associated with patients who contained the rare alleles. Our data suggest that the short rare alleles of BORIS-MS2 could be used to identify the risk for breast cancer in young patients.
ISSN:1976-6696
1976-670X
DOI:10.5483/BMBRep.2010.43.10.698